| LEADER |
03351nam a22002777a 4500 |
| 001 |
2290551 |
| 041 |
|
|
|a eng
|
| 044 |
|
|
|b الأردن
|
| 100 |
|
|
|9 820554
|a Alshehri, Mohammed Abdullah Ali
|e Author
|
| 245 |
|
|
|a A Systematic Review of the Interplay between Covid-19 and Non-Communicable Diseases
|
| 260 |
|
|
|b مركز البحث وتطوير الموارد البشرية - رماح
|c 2024
|g أكتوبر
|
| 300 |
|
|
|a 1 - 8
|
| 336 |
|
|
|a بحوث ومقالات
|b Article
|
| 520 |
|
|
|b Since the onset of 2020, the COVID-19 pandemic has had a profound global impact. With the rising cases and fatalities, particular attention has been directed to individuals with non-communicable diseases (NCDs), who are especially vulnerable to the virus. This literature review aims to consolidate existing evidence regarding the relationship between NCDs and COVID-19. Methods: A systematic review of literature related to COVID-19 and non-communicable diseases was conducted, covering the period from January 2020 to May 2020. The search was performed on PubMed, utilizing a range of search terms to refine the final selection of studies. Ultimately, 25 papers were included in this review. Results: The findings indicate that individuals with specific chronic conditions, including diabetes, hypertension, cardiovascular diseases, chronic respiratory diseases, and chronic kidney and liver disorders, are at a heightened risk of severe COVID-19 outcomes. Importantly, once infected, these patients are significantly more likely to experience severe disease progression or mortality compared to the general population. Two primary mechanisms are proposed to explain this association: first, increased expression of ACE2 (angiotensin-converting enzyme 2) receptors, which facilitates viral entry; and second, a hyperinflammatory response, commonly referred to as a "cytokine storm." Notably, the review found no evidence suggesting that medications for diabetes or hypertension worsen the COVID-19 condition in patients with chronic illnesses. Conclusions: The evidence supports a continued standard approach to disease management for patients with NCDs, albeit with enhanced monitoring. However, due to the ongoing vulnerabilities presented by COVID-19, prioritizing individuals with NCDs for vaccination should be a key focus for health authorities.
|
| 653 |
|
|
|a الرعاية الصحية
|a الأمراض المعدية
|a معدل الوفيات
|a جائحة كورونا "كوفيد-19"
|
| 692 |
|
|
|b Non-Communicable Diseases
|b COVID-19
|b Clinical Outcomes
|
| 700 |
|
|
|9 820556
|a Alatifi, Waleed Khalid Abdulqader
|e Co-Author
|
| 700 |
|
|
|9 820558
|a Alqahtani, Salem Mohammed Ibn Salem
|e Co-Author
|
| 700 |
|
|
|9 820565
|a Alshahrani, Abdullah Mohammed Muflih
|e Co-Author
|
| 700 |
|
|
|9 820566
|a Alshahrani, Othman Nasser Mohammed
|e Co-Author
|
| 773 |
|
|
|4 العلوم الإنسانية ، متعددة التخصصات
|4 العلوم الاجتماعية ، متعددة التخصصات
|6 Humanities, Multidisciplinary
|6 Social Sciences, Interdisciplinary
|c 001
|e Arab journal for scientific publishing
|f al-Mağallaẗ al-ʿarabiyyaẗ li-l-našr al-ilmī
|l 072
|m ع72
|o 2502
|s المجلة العربية للنشر العلمي
|v 000
|x 2663-5798
|
| 856 |
|
|
|u 2502-000-072-001.pdf
|
| 930 |
|
|
|d y
|p y
|q n
|
| 995 |
|
|
|a EduSearch
|
| 995 |
|
|
|a HumanIndex
|
| 999 |
|
|
|c 1547431
|d 1547431
|
